Patients with Substance Use and Personality Disorders: A Comparison of Patient Characteristics, Treatment Process, and Outcomes in Swiss and U.S. Substance Use Disorder Programs

Abstract

Treatment evaluation findings from representative programs in one country may apply elsewhere and contribute to our overall knowledge about how to improve SUD-PD patients' outcomes.

Self‐Efficacy as a Predictor of Outcome After Residential Treatment Programs for Alcohol Dependence: Simply Ask the Patient One Question!

“…Program characteristics are described in more detail and compared with residential AUD programs affiliated with the U.S. Department of Veterans Affairs Health Care System in 2 publications by Moggi and colleagues (, ). Overall, Swiss programs were 5 times longer (122 days) than U.S. programs, offered more individual and fewer group sessions, focused on substance abuse, were clearly less 12‐step/AA oriented, but similarly cognitive‐behavioral treatment oriented, and emphasized the disease model less, but similarly emphasized the psychosocial model of understanding SUDs.…”

Depressive symptoms as a predictor of alcohol relapse after residential treatment programs for alcohol use disorder

“…Program characteristics are described in more detail and compared with residential AUD programs affiliated with the U.S. Department of Veterans Affairs Health Care System in two publications by Moggi, Giovanoli, Buri, Moos, and Moos (2010) and Moggi, Giovanoli, Strik, Moos, and Moos (2007). Overall, Swiss programs were five times longer (122 days) than U.S. programs, offered more individual and fewer group sessions, focused on substance abuse, were clearly less 12-step/AA but similarly cognitive-behavioral treatment oriented, and emphasized the disease model less but similarly the psychosocial model of understanding SUDs.…”

Exploring Relationships between Adult Attachment, Spirituality and Personality Disorder Traits among Individuals in In-patient Treatment for Substance Use Disorders

“…However, the most recent edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM5; American Psychiatric Association [APA], 2013) contains the criteria used for diagnosing ten distinct PDs, often categorized into three clusters, A, B and C. Cluster A contains those disorders with odd or eccentric affects and behaviors, paranoid, schizoid and schizotypal; Cluster B contains those disorders with dramatic, emotional and/or erratic affects and behaviors, antisocial, borderline, histrionic and narcissistic; Cluster C contains those disorders with anxious/fearful affects and behaviors, avoidant, dependent and obsessive-compulsive. The great majority of studies on PD and substance use has not included all ten of the disorders in their focus or analysis (e.g., Grant, Stinson, Dawson, Chou, & Ruan, 2005;Grant et al, 2004;Moggi, Giovanoli, Buri, Moos, & Moos, 2010;Sonneborn & Bosma, 2011;Zikos et al, 2010) and most have focused on Cluster B (e.g., Bandelow, Schmahl, Falkai, & Wedekind, 2010;Gratz, Tull, Baruch, Bornavalova, & Lejuez, 2008;Lee, Bagge, Montgomery, Schumacher, & Coffey, 2010;Sansone & Sansone, 2011;Strausner & Nemenzik, 2007;Walter et al, 2008). Thus, there is a gap in the literature concerning the risk and protective factors associated with individual PDs comorbid with SUD.…”